LAE-32
From Wikipedia, the free encyclopedia
 |
This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
 |
|
|---|---|
| Systematic (IUPAC) name | |
| (8β)- N- ethyl- 6-methyl- 9,10- didehydroergoline- 8-carboxamide | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Oral |
| Pharmacokinetic data | |
| Metabolism | hepatic |
| Excretion | renal |
| Identifiers | |
| CAS number | 478-99-9 |
| ATC code | ? |
| PubChem | CID 101704 |
| ChemSpider | 19975296  |
| Synonyms | LAE, Lysergic acid ethylamide, d-lysergic acid ethylamide, d-ethyllysergamide, |
| Chemical data | |
| Formula | C18H21N3O |
| Mol. mass | 295.378 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
D-Lysergic Acid Ethylamide, (LAE-32) is a derivative of ergine. It is reported to have some LSD-like effects but is weaker and shorter lasting, with an active dose reported to be between 0.5 and 1.5 milligrams.
 |
This psychedelics, dissociatives and deliriants-related article is a stub. You can help Wikipedia by expanding it. |
